- A six-month clinical trial on a new-generation thin strut fully dissolvable stent in the world has thrown up "encouraging results"
- It could be a boon for the treatment of coronary artery disease, which is a global killer.
- "The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available bioresorbable stents (BRS) and may have higher success and lower complication rates in the long-term," said Dr Ashok Seth, Chairman of the Fortis Escorts Heart Institute (FEHI), who led the study.
- The findings of the trial were revealed at a global conference -- The Cardiovascular Therapeutics (TCT) 2016, in USA
- Coronary heart disease is a cardiovascular disease caused by narrowing of coronary arteries by a build-up of fatty material within their walls.
- "It (stent) would also cost much less than the currently available dissolvable stents and therefore give more benefit to higher number of patients," Seth said.
- WHO says that an estimated 17.5 million people died from Cardio Vascular Diseases in 2012, representing 31 per cent of all global deaths.
Read Full News Here: India Today